Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
305.06
-5.21 (-1.68%)
At close: Nov 17, 2026, 4:00 PM EST
307.00
+1.94 (0.64%)
After-hours: Nov 17, 2026, 7:30 PM EST
PRAX Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
168
Market Cap
8.53B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 8.55M | 6.11M | 249.53% |
| Dec 31, 2023 | 2.45M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Madrigal Pharmaceuticals | 1.43B |
| Corcept Therapeutics | 963.65M |
| TG Therapeutics | 897.76M |
| Protagonist Therapeutics | 551.69M |
| Krystal Biotech | 470.03M |
| Rhythm Pharmaceuticals | 280.75M |
| Cytokinetics | 113.29M |
| Kymera Therapeutics | 102.24M |
PRAX News
- 21 hours ago - Praxis Precision upgraded to Overweight from Equal Weight at Wells Fargo - TheFly
- 1 day ago - Praxis Precision price target lowered to $1,050 from $8,000 at Guggenheim - TheFly
- 1 day ago - Praxis Precision price target raised to $568 from $514 at Baird - TheFly
- 1 day ago - Praxis Precision Medicines Transcript: UBS Global Biopharma Conference 2026 - Transcripts
- 5 days ago - Praxis Precision Medicines Details Launch Readiness for Relutrigine and Ulixacaltamide and Outlines Expanded Pipeline in Preparation to be the Preeminent CNS Biotech at Investor Day - GlobeNewsWire
- 5 days ago - Praxis Precision Medicines Transcript: Investor Day 2026 - Transcripts
- 5 days ago - Praxis Precision Medicines Press release: FY 2026 - Filings
- 5 days ago - Praxis Precision Medicines Slides: FY 2026 - Filings